Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides

Journal of Virology

Volumn 83, Issue 17, 2009, Pages 9008-9012

  Wang, Yang ^a   Flesch, Inge E A ^a   Tscharke, David C ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; PEPTIDE; VIRUS VECTOR; INTERFERON GAMMA (1 39); INTERFERON GAMMA (1-39); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINIA VIRUS; ANIMAL; C57BL MOUSE; IMMUNOLOGY; SECRETION;

MUS; VACCINIA VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; IMMUNIZATION, SECONDARY; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; VACCINIA VIRUS;

EID: 69249211167     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00410-09     Document Type: Article

References (20)

1. Chen, W., L. C. Anton, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83-93. (Pubitemid 30069217)
2. + cytotoxic T lymphocyte population. Int. Immunol. 14:31-37.
3. Harrington, L. E., R. van der Most, J. L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76:3329-3337.
4. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
5. Lev, A., K. Takeda, D. Zanker, J. C. Maynard, P. Dimberu, E. Waffarn, J. Gibbs, N. Netzer, M. F. Princiotta, L. Neckers, D. Picard, C. V. Nicchitta, W. Chen, Y. Reiter, J. R. Bennink, and J. W. Yewdell. 2008. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 28:787-798. (Pubitemid 351778406)
6. McConkey, S. J., W. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, C. M. Hannan, S. Everaere, K. Brown, K. E. Kester, J. Cummings, J. Williams, D. G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M. T. Roberts, M. Roy, G. L. Smith, J. Schneider, T. Peto, R. E. Sinden, S. C. Gilbert, and A. V. Hill. 2003. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9:729-735.
7. Moore, A. C., and A. V. Hill. 2004. Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol. Rev. 199:126-143.
8. CD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24:817-819.
9. Oseroff, C., B. Peters, V. Pasquetto, M. Moutaftsi, J. Sidney, V. Panchanathan, D. C. Tscharke, B. Maillere, H. Grey, and A. Sette. 2008. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus Western Reserve. J. Immunol. 180:7193-7202.
10. + T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon. J. Virol. 76:4251-4259.
11. Schmidt, N. W., R. L. Podyminogin, N. S. Butler, V. P. Badovinac, B. J. Tucker, K. S. Bahjat, P. Lauer, A. Reyes-Sandoval, C. L. Hutchings, A. C. Moore, S. C. Gilbert, A. V. Hill, L. C. Bartholomay, and J. T. Harty. 2008. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. USA 105:14017-14022.
12. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
13. Silk, J. D., I. F. Hermans, U. Gileadi, T. W. Chong, D. Shepherd, M. Salio, B. Mathew, R. R. Schmidt, S. J. Lunt, K. J. Williams, I. J. Stratford, A. L. Harris, and V. Cerundolo. 2004. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Investig. 114:1800-1811.
14. Smith, C. L., F. Mirza, V. Pasquetto, D. C. Tscharke, M. J. Palmowski, P. R. Dunbar, A. Sette, A. L. Harris, and V. Cerundolo. 2005. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J. Immunol. 175:8431-8437.
15. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201:95-104.
16. Yap, K. L., G. L. Ada, and I. F. McKenzie. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:238-239. (Pubitemid 8331715)
17. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histo-compatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88.
18. CD8+ responses to viruses: cell biology, cellular immunology, and mathematical models. Immunity 21:149-153.
19. + T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23:651-682.
20. Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51-177.